BioRestorative Therapies Inc BRTX:NASDAQ

Last Price$2.83Cboe Previous Close - Real-Time Last Sale as of 3:52PM ET 9/22/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$2.65 (3)
Ask (Size)$2.68 (3)
Day Low / HighN/A - N/A
Volume12.1 K

BioRestorative Therapies Secures Second Site for Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease; Shares Rise Pre-Bell

8:13AM ET 6/22/2022 MT Newswires
BioRestorative Therapies (BRTX) said Wednesday it has entered into an agreement with a second site for a Phase 2 clinical trial of its investigational stem cell-based therapeutic BRTX-100 targeting chronic lumbar disc disease.

The Center for Clinical Research, located in North Carolina, is its second clinical trial contract secured, the company said. The Denver Spine and Pain Institute was the first site initiated for the trial, the company announced on June 13.

The Phase 2 trial will assess the safety and preliminary efficacy of a single dose injection of BRTX-100, while up to 99 eligible patients will be randomized at up to 15 sites in the US, the company said.

The company shares were up 12% ahead of Wednesday's opening.

Price: 4.15, Change: +0.46, Percent Change: +12.52